Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / American Depositary Shares
-
Shares outstanding
-
60.8M
-
Number of holders
-
165
-
Total shares
-
63.2M
-
Shares change
-
+1.3M
-
Total reported value, excl. options
-
$5.87B
-
Value change
-
+$99.3M
-
Put/Call ratio
-
0.47
-
Number of buys
-
77
-
Number of sells
-
-85
-
Price
-
$92.96
Significant Holders of Ascendis Pharma A/S - American Depositary Shares (ASND) as of Q2 2022
170 filings reported holding ASND - Ascendis Pharma A/S - American Depositary Shares as of Q2 2022.
Ascendis Pharma A/S - American Depositary Shares (ASND) has 165 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63.2M shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (7.57M shares), Artisan Partners Limited Partnership (7.47M shares), FMR LLC (5.29M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.17M shares), BAKER BROS. ADVISORS LP (4.85M shares), JANUS HENDERSON GROUP PLC (3.86M shares), WELLINGTON MANAGEMENT GROUP LLP (3.55M shares), GOLDMAN SACHS GROUP INC (3.32M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (2.79M shares), and Avoro Capital Advisors LLC (2.28M shares).
This table shows the top 165 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.